Stocks · Health care · Biological Products, (No Diagnostic Substances)

Amgen

AMGN Clue Score50

United States Fiscal year ends December CIK 0000318154 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

40 insiders · 96 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Esteban Santos

EVP, Operations

—

$23.32M (3) scheduled

−$23.32M

82,847

0.0153%

$34.50M

+176.6%

Jonathan P Graham

EVP & Gen. Counsel & Sec.

—

$18.04M (5)

−$18.04M

39,712

0.0073%

$16.54M

−25.1%

David M Reese

EVP & Chief Technology Officer

—

$10.23M (2)

−$10.23M

42,256

0.0078%

$17.60M

+69.0%

Murdo Gordon

EVP, Global Commercial Ops

—

$7.41M (3)

−$7.41M

51,222

0.0095%

$21.33M

+945.1%

Ronald D Sugar

Director

—

$6.22M (20) scheduled

−$6.22M

19,682

0.0036%

$8.20M

+54.7%

Nancy A. Grygiel

SVP & CCO

—

$5.54M (11) scheduled

−$5.54M

7,340

0.0014%

$3.06M

+67.6%

Tyler Jacks

Director

—

$3.91M (1) scheduled

−$3.91M

18,284

0.0034%

$7.61M

+100.3%

Cynthia M Patton

SVP & CCO

—

$3.61M (5) scheduled

−$3.61M

24,751

0.0046%

$10.31M

+16.1%

Sean E Harper

EVP, Research & Development

—

$2.76M (10)

−$2.76M

56,082

0.0104%

$23.35M

+17.4%

Rachna Khosla

SVP, Business Development

—

$2.19M (5)

−$2.19M

6,404

0.0012%

$2.67M

+41.2%

Derek Miller

SVP, Human Resources

—

$2.16M (4) scheduled

−$2.16M

12,462

0.0023%

$5.19M

+99.8%

David Piacquad

SVP, Business Development

—

$2.13M (1)

−$2.13M

44,787

0.0083%

$18.65M

+15.3%

David W Meline

EVP & CFO

—

$2.05M (1)

−$2.05M

49,378

0.0091%

$20.56M

+2.9%

Robert Eckert

Director

—

$1.64M (1)

−$1.64M

26,251

0.0049%

$10.93M

+150.3%

R Sanders Williams

Director

—

$813.32K (10)

−$813.32K

6,240

0.0012%

$2.60M

+124.5%

Carbonnel Francois de

Director

—

$694.42K (1)

−$694.42K

16,426

0.0030%

$6.84M

−12.0%

Matthew C. Busch

VP, Finance & CAO

—

$655.48K (2)

−$655.48K

5,080

0.0009%

$2.12M

+6.8%

David Baltimore

Director

—

$569.54K (1)

−$569.54K

32,286

0.0060%

$13.44M

−4.0%

Robert A Bradway

Chairman, CEO and President

—

—

—

595,160

0.1101%

$247.84M

+91.4%

Anthony C Hooper

EVP, Global Commercial Ops.

—

—

—

215,147

0.0398%

$89.59M

+13.0%

Brian M McNamee

EVP

—

—

—

102,516

0.0190%

$42.69M

+13.5%

Peter H. Griffith

EVP & CFO

—

—

—

50,150

0.0093%

$20.88M

+122.3%

Lori A Johnston

EVP, HR

—

—

—

40,881

0.0076%

$17.02M

+300.0%

Frank Biondi

Director

—

—

—

36,635

0.0068%

$15.26M

+3.5%

Frank C Herringer

Director

—

—

—

35,522

0.0066%

$14.79M

+10.9%

James E. Bradner

EVP, Research and Development

—

—

—

30,016

0.0056%

$12.50M

+1,539%

Rebecca M Henderson

Director

—

—

—

17,974

0.0033%

$7.48M

+56.3%

Ellen Jamison Kullman

Director

—

—

—

14,536

0.0027%

$6.05M

+474.3%

Greg C. Garland

Director

—

—

—

13,848

0.0026%

$5.77M

+195.0%

Charles M Holley

Director

—

—

—

12,990

0.0024%

$5.41M

+2,978%

Judith C Pelham

Director

—

—

—

11,232

0.0021%

$4.68M

+12.3%

Linda H. Louie

VP, Finance & CAO

—

—

—

9,966

0.0018%

$4.15M

+56.5%

Fred Hassan

Director

—

—

—

9,191

0.0017%

$3.83M

+89.1%

Annette Louise Such

VP, Finance and CAO

—

—

—

8,478

0.0016%

$3.53M

+16.7%

Brian Druker

Director

—

—

—

8,391

0.0016%

$3.49M

+816.0%

Wanda M Austin

Director

—

—

—

8,018

0.0015%

$3.34M

—

Omar Ishrak

Director

—

—

—

7,486

0.0014%

$3.12M

+1,079%

Michael Drake V

Director

—

—

—

5,876

0.0011%

$2.45M

+1,459%

Amy E Miles

Director

—

—

—

5,640

0.0010%

$2.35M

+1,282%

Mary E. Klotman

Director

—

—

—

2,211

0.0004%

$920.72K

+12,183%